BIBLIOGRAFÍA

1. SAFARY A; BECK J. Vaccination against hepatitis B: current challenges Far Asian Countries and future directions . J Gastroenterol hepatol 2,000; 15 (4), 396-401

2. WORLD HEALTH ORGANIZATION.WHOexpanded programme on immunization .Report of 14th Global Advisory Group(Antalya,Turkey,Oct. 14-18,1991)Geneva:WHO,1991:WHO/EPI/GEN/92.1

3. KANE A.M Status of hepatitis B immunization programme in 1998.Vaccine 1998;16(Suppl):S 104-108

4. KANE a.m. global status of hepatitis immunization.Lancet 1996;348:696

5. BEASLEY R.P. Hepatitis B virus: the major etiology of hepatocellular carcinoma. Cancer 1998; 61: 1942-56

6. TANDON BN, TANDONA. Epidemiological trends of viral hepatitis in Asia. In: Rizzetto M, Purcell RH.

7. GERIN JL, Vernue G, eds. Viral hepatitis and Liver Desease, Turin: Edizioni Minerva Medica, 1997; 559-61

8. KANEM, CLEMENTS J, HUD. Hepatitis B. In: Jamsom dt, Mosley WH Measham AR, Bobadilla IL eds .Disease Control Priorities in Developing Countries Washington; DC: Oxford University Press, 193; 321-30

9. VILDOSOLA H.,FARFAN G.,COLAN E.,DELGADO G.,y col.Prevalencia del antígeno de superficie del virus de la hepatitis B en población general de Costa, Sierra y Selva del Perú Reporte preliminar.Rev Gastroent Perú. 1990;10:96-101

10. MENDEZ M.,ARCE M.,y col Prevalencia de marcadores serológicos de hepatitis vírica en diversos grupos de población del Perú.Bol Of Panam 1989;106:127-138

11. COLICHON A. Distribución seroepidemiológica de la hepatitis B y hepatitis Delta en diferentes comunidades indígenas de la selva peruana. Tesis Doctoral. UPCH Lima,1989

12. RUIZ R. Marcadores serológicos de hepatitis viral en la región amazónica del Perú. Diagnóstico 1989;24:5-9

13. HSU HY,CHANG MH,CHEN DS et al.Baseline seroepidemiology of hepatitis B virus infection in children in Taipei,1984:A study just before mass hepatitis B vaccination program of Taiwan. J Med Virol 1986;18:301-7

14. FERET E, LAROUZE B, DiIOB B et al Epidermiology of hepatitis B virus infection in the rural community of tip, Senegal. Am J epidemiol 1987, 125:140-9

15. STEVENS CE, BEASLEY R.P, TSUI J, LEE WC Vertical Transmission of hepatitis B antigen in Taiwan N Engl J Med 1975; 292: 771-4

16. TANDON BN, ACHARYA SK, TANDONA. Epidemiology of hepatitis B virus infecction in India. Gue 1996; 39 (suppl 2): S56-9

17. ZUCKERMAN A.J. Prevention of Primary Liver Cancer by inmuniztion (Editorial) N Engl J M 1997; 336 (26): 1906-7 

18. MEI-HWEI CHANG. Vaccination against hepatitis viruses, inpact on hepatitis B virus and associated deseases. “Hepatology into the next Millenium” lesson from the past-issues for the future.Postgraduate Course, 1999.Dallas Texas

19. BRECHOT C. Molecular mediamisms of hepatitis B and C viruses related Liver carcinogenasis -In Rizzetto M, Purcell RH,Gerin J.L, Verme G eds

20. BEASLEY LA HWANGLY, LINCE, CHIENCS. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22707 men in taiwan. Lancet 1981; 2: 1129-23

21. LONDON WT. Primary hepatocellular carcinoma-etiology, pathogenesis, and prevention. Hum Pathol 1981; 12:1085-97

22. ARCE R,LEON J,CUELLAR L.Antigeno de superficie del virus de la hepatitis B causante del hepatocarcinoma.Rev Gastroent Perú1986;6:36-45.

23. ARANA J, BURSTEIN M, FLORES P y col.Cáncer primario de hígado. Libro de Resúmenes XI Congreso Peruano de Gastroenterología 22-25 Nov. 1988,Lima-Perú.

24. ZUMAETA E, FIGUEROA R, NAVARRETE J, Cáncer primario de hígado en el Hospital Nacional “Edgardo Rebagliatti Martins” IPSS. Lima Perú. Libro de Resúmenes XIII Congreso Peruano de Enfermedades Digestivas.15-20 Nov. 1992;pag.40.Lima Perú.

25. CHANG MH, CHEN DS, HSU HC, HSU HY, LEE CY. Maternal transmissión of hepatitis B virus in childhood hepatocellular carcinoma.Cancer 1989;64:2377-80

26. BEASLEY RP,HWANG LY, LIN CC et al.Hepatitis B immune globulin(HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state.Lancet 1981;1:388-93

27. HSU NMS,CHEN DS,CHUANG CH, et al.Efficacy of a mass hepatitis B vaccination program in Taiwan:Studies on 3464 infants of hepatitis B sur-face antigen-carrier mothers.JAMA 1988;260:2231-5

28. ALTER MJ,HADLER SC ,MARGOLIS HS ET AL.The changing epidemiology of hepatitis B in the United States .Need for alternative vaccination strategies. JAMA 1990;230:1218-22

29. DA VILLA G, PICCIOTOC L, ELIA S, PELUSO F, MONTANARO F,et al. Hepatitis B vaccination:universal vaccination of newborn babies and children at 12 years of age versus high risk groups.A comparison in the filed.Vaccine 1995;13:1240-3

30. EUROPEAN CONSENSUS GROUP ON HEPATITIS B IMMUNITY .Are booster immunizations needed for lifelong hepatitis B immunity?.Lancet 2000;355:561-65

31. CHEN HL, CHANG MH, NI YH,et al .Seroepidemiology of hepatitis B virus infection children –Ten years of mass vaccination in Taiwan.JAMA 1996;276:906-8

32. DA VILLA F, PICCININO C SCOLASTICO M, et al. Long-term epidemiological survey of hepatitis B virus infection in a hyperendemic area (Afragola,southern Italy):results of a pilot vaccination project.Res Virol 1998;149(5):263-70

33. VIVIANI S, JACK A, HALL AJ, et al. Hepatitis B vaccination in infancy in the Gambia: protection against carriage at 9 years of age.Vaccine 1999;17(23-24):2946-50

34. COURSAGET P, LEBOULLEUX D, SOUMRE M, et al. Twelve-year follow-up study of hepatitis B immunization of senegalese infants. J Hepatology 1994;21(2):250-4

35. CABEZAS C, RAMOS F, VEGA M, SUAREZ M, ROMERO G et al Impacto del programa de vacunación contra hepatitis viral B (HVB) integrado al programa Ampliado de inmunizaciones (PAI) en Huanta (Perú) 1994-1997. Rev Gastroent Perú 2000; 20:201-212 

36. CHANG MH, CHEN CJ, LAI MS et al, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 1997;336:1855-9

37. CHANG MH, CHEN CJ, CHEN JY et al Hepatitis B virus integration in hepatitis B virus –related hepatocellular carcinoma in chilhood.Hepatology 1991;13:316-20.

REGRESAR AL ARTÍCULO

Regresar